Benzenesulfonamide

Benzenesulfonamide

SCHEMBL8031983

NS(=O)(=O)c1ccccc1.O=S(=O)(Nn1nc(C(F)(F)F)cc1-c1ccc(F)cc1)c1ccccc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.58
PTGS1 P23219 9/20 0.58
PDPK1 O15530 6/20 0.55
CYP2C9 P11712 2/20 0.47
PTGES O14684 1/20 0.47
HDAC3 O15379 1/20 0.47
CA12 O43570 1/20 0.47
PDE5A O76074 1/20 0.47
ABCB11 O95342 1/20 0.47
MT-CO2 P00403 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
LMNA P02545 1/20 0.47
CA3 P07451 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALOX5 P09917 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CYP2D6 P10635 1/20 0.47
ADRB3 P13945 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8636828 0.94 PDPK1 (0.61) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL8351386 0.94 PTGS2 (0.49) PTGS2PTGS1PDPK1
Benzenesulfonamide SCHEMBL7113357 0.90 PTGS2 (0.59) PTGS2PTGS1PDPK1CYP2C9
Benzenesulfonamide SCHEMBL8525050 0.87 PTGS2 (0.61) PTGS2PTGS1PDPK1
Benzenesulfonamide SCHEMBL7926068 0.87 PTGS2 (0.61) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL8640765 0.87 PTGS1 (0.51) PTGS2PTGS1PDPK1
SCHEMBL8643571 0.86 PTGS2 (0.51) PTGS2PTGS1PDPK1CYP2C9
SCHEMBL8643881 0.85 PTGS2 (0.40) PTGS2PTGS1TSHR
SCHEMBL8643941 0.85 PTGS2 (0.42) PTGS2PTGS1PDPK1
SCHEMBL8641577 0.85 PTGS2 (0.49) PTGS2PTGS1PDPK1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979077-A1 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE PREVENTION OF CARDIOVASCULAR DISORDERS G.D. Searle & Co. (US) 2000-02-16 EP disclosed
EP-0932402-A1 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA G.D. SEARLE & CO. (US) 1999-08-04 EP disclosed
WO-1998047509-A1 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE PREVENTION OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1998-10-29 WO disclosed
WO-1998016227-A1 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA G.D. SEARLE & CO. (US) 1998-04-23 WO disclosed